121 related articles for article (PubMed ID: 11391538)
1. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
Mehta A; Carrouée S; Conyers B; Jordan R; Butters T; Dwek RA; Block TM
Hepatology; 2001 Jun; 33(6):1488-95. PubMed ID: 11391538
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
3. Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ.
Mehta A; Ouzounov S; Jordan R; Simsek E; Lu X; Moriarty RM; Jacob G; Dwek RA; Block TM
Antivir Chem Chemother; 2002 Sep; 13(5):299-304. PubMed ID: 12630678
[TBL] [Abstract][Full Text] [Related]
4. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
[TBL] [Abstract][Full Text] [Related]
5. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
[TBL] [Abstract][Full Text] [Related]
6. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
[TBL] [Abstract][Full Text] [Related]
7. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging.
Feld JJ; Colledge D; Sozzi V; Edwards R; Littlejohn M; Locarnini SA
Antiviral Res; 2007 Nov; 76(2):168-77. PubMed ID: 17709147
[TBL] [Abstract][Full Text] [Related]
8. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
Lu X; Mehta A; Dwek R; Butters T; Block T
Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
[TBL] [Abstract][Full Text] [Related]
9. Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins.
Jacob JR; Mansfield K; You JE; Tennant BC; Kim YH
J Microbiol; 2007 Oct; 45(5):431-40. PubMed ID: 17978803
[TBL] [Abstract][Full Text] [Related]
10. The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture.
Lu X; Tran T; Simsek E; Block TM
J Virol; 2003 Nov; 77(22):11933-40. PubMed ID: 14581530
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific antiviral activity of iminosugars against human influenza A viruses.
Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW
J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
[TBL] [Abstract][Full Text] [Related]
14. Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus.
Gu B; Mason P; Wang L; Norton P; Bourne N; Moriarty R; Mehta A; Despande M; Shah R; Block T
Antivir Chem Chemother; 2007; 18(1):49-59. PubMed ID: 17354651
[TBL] [Abstract][Full Text] [Related]
15. [Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis].
Timokhova AV; Bakinovskiĭ LV; Zinin AI; Popenko VI; Ivanov AV; Rubtsov PM; Kochetkov SN; Belzhelarskaia SN
Mol Biol (Mosk); 2012; 46(4):644-53. PubMed ID: 23113354
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.
Block TM; Lu X; Mehta AS; Blumberg BS; Tennant B; Ebling M; Korba B; Lansky DM; Jacob GS; Dwek RA
Nat Med; 1998 May; 4(5):610-4. PubMed ID: 9585237
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
18. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus mutations associated with antiviral therapy.
Bartholomeusz A; Locarnini S
J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of hepatitis B virus associated DNA polymerase by antiviral agents: in vitro studies with clinical implications (author's transl)].
Hess G; Arnold W; Hütteroth TH; Meyer zum Büschenfelde KH
Z Gastroenterol; 1981 Jul; 19(7):338-44. PubMed ID: 6457451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
